• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by NANO-X IMAGING LTD (Amendment)

    12/21/21 3:27:06 PM ET
    $NNOX
    Medical Electronics
    Health Care
    Get the next $NNOX alert in real time by email
    SC 13G/A 1 brhc10031899_sc13ga.htm SC 13G/A
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G
    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

    Nano-X Imaging Ltd.
    (Name of Issuer)

    Ordinary Shares
    (Title of Class of Securities)

    M70700105
    (CUSIP Number)
     
    November 22, 2021
    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    Rule 13d-1(b)
     
    Rule 13d-1(c)
     
    Rule 13d-1(d)
     
    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
     
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     


    CUSIP No. M70700105
    Page 2 of 5 Pages

    1
    NAMES OF REPORTING PERSONS
     
     
    Moshe Moalem
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Israel
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    2,126,473
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    0
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    2,126,473
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    0
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    2,126,473
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    4.4%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    IN
     
     
     
     


    CUSIP No. M70700105
    Page 3 of 5 Pages

    ITEM 1(a).
    NAME OF ISSUER
     
    Nano-X Imaging Ltd. (the “Issuer”).
     
    ITEM 1(b).
    ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES

    Communications Center, Neve Ilan, Israel 9085000
     
    ITEM 2(a).
    NAME OF PERSONS FILING
     
    Moshe Moalem
     
    ITEM 2(b).
    ADDRESS OF PRINCIPAL BUSINESS OFFICE
     
    39 Shamgar St., Tel Aviv, Israel 6993592
     
    ITEM 2(c).
    CITIZENSHIP
     
    Israel
     
    ITEM 2(d).
    TITLE OF CLASS OF SECURITIES
     
    Ordinary shares of the Issuer
     
    ITEM 2(e).
    CUSIP NUMBER
     
    M70700105
     
    ITEM 3.
    If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
     

    (a)           ☐         
    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
     

    (b)           ☐         
    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
     

    (c)           ☐         
    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
     

    (d)           ☐          Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
     

    (e)           ☐         An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
     

    (f)           ☐          An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
     

    (g)           ☐          A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
     

    (h)           ☐          A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
     

    (i)           ☐          A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
     

    (j)           ☐          A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
     

    CUSIP No. M70700105
    Page 4 of 5 Pages


    (k)          ☐          Group, in accordance with § 240.13d-1(b)(1)(ii)(K).
                       
    ITEM 4.
    OWNERSHIP
     

    (a)
    Amount beneficially owned: 2,126,473 ordinary shares
     

    (b)
    Percent of class: 4.4%
     
    (c)
     

    (i)
    Sole power to vote or direct the vote: 2,126,473 ordinary shares
     

    (ii) Shared power to vote or direct the vote: 0
     

    (iii) Sole power to dispose or to direct the disposition of: 2,126,473 ordinary shares
     

    (iv) Shared power to dispose or to direct the disposition of: 0
     
    ITEM 5.
    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
     
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☒.
     
    ITEM 6.
    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
     
    Not applicable.
     
    ITEM 7.
    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON
     
    Not applicable.
     
    ITEM 8.
    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
     
    Not applicable.
     
    ITEM 9.
    NOTICE OF DISSOLUTION OF GROUP
     
    Not applicable.
     
    ITEM 10.
    CERTIFICATION
     
    Not applicable.


    CUSIP No. M70700105
    Page 5 of 5 Pages

    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    DATE:
    December 21, 2021
     
    MOSHE MOALEM
     
      /s/ Moshe Moalem



    Get the next $NNOX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NNOX

    DatePrice TargetRatingAnalyst
    1/6/2025$23.00Buy
    D. Boral Capital
    9/8/2023$14.50Buy
    Alliance Global Partners
    1/5/2023$21.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $NNOX
    Financials

    Live finance-specific insights

    See more
    • Nanox to Report First Quarter 2025 Financial Results on May 22, 2025

      PETACH TIKVA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2025, before market open on Thursday, May 22, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q1 2025 Earnings Call Registration. The live webcast of the conference call may be

      5/8/25 4:03:00 PM ET
      $NNOX
      Medical Electronics
      Health Care
    • Nanox to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025

      PETACH TIKVA, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2024, before market open on Monday, March 31, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q4 Earnings Call Registration. The live webcast of the conferenc

      3/17/25 4:05:00 PM ET
      $NNOX
      Medical Electronics
      Health Care
    • Nanox Announces Third Quarter of 2024 Financial Results and Provides Business Update

      Made progress deploying all components of the Nanox solution including Nanox.ARC and Nanox.AI Expanded US sales and support staff a key component of global strategic growth plan Management to host conference call and webcast Thursday, November 21, 2024 at 8:30 AM ET PETACH TIKVA, Israel, Nov. 21, 2024 (GLOBE NEWSWIRE) -- November 21, 2024 — NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the third quarter ended September 30, 2024 and provided a business update. Recent Highlights: Generated $3.0 million in revenue in the third quarter of 2024, compared to $2.5 million in the third quarter of 2023

      11/21/24 8:00:00 AM ET
      $NNOX
      Medical Electronics
      Health Care

    $NNOX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Nanox to Report First Quarter 2025 Financial Results on May 22, 2025

      PETACH TIKVA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2025, before market open on Thursday, May 22, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q1 2025 Earnings Call Registration. The live webcast of the conference call may be

      5/8/25 4:03:00 PM ET
      $NNOX
      Medical Electronics
      Health Care
    • Nanox Receives FDA Clearance for General Use of New Imaging System, Nanox.ARC X

      First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indicationsEnhanced imaging system features sleek design with smaller footprint; simplified ‘plug and play' installation processSystem design enables software upgrades and new capabilities to be added remotely following future regulatory clearances PETACH TIKVA, Israel, April 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Nanox.ARC X

      4/17/25 8:30:54 AM ET
      $NNOX
      Medical Electronics
      Health Care
    • Nanox to Present New Data Featuring AI Bone Solution at Four Medical Conferences through June 2025 across Europe

      ADOPT Study Findings Highlight Nanox.AI's Role in Enhancing Fracture Detection and Healthcare Cost Savings PETACH TIKVA, Israel, March 26, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that its deep-learning medical imaging analytics subsidiary, Nanox AI Ltd will present new data from the AI-enabled Detection of OsteoPorosis for Treatment (ADOPT) study at four major upcoming medical conferences spanning March through June 2025. The ADOPT study concluded in February 2025 and evaluated HealthVCF at four National Health Services (NHS) trusts: Cambridge, Bradford, Cardiff and

      3/26/25 7:00:13 AM ET
      $NNOX
      Medical Electronics
      Health Care

    $NNOX
    Leadership Updates

    Live Leadership Updates

    See more
    • Nanox Announces Appointment of Medical Executive Moshe Shtengel as Chief Business Officer

      NEVE ILAN, Israel, May 03, 2021 (GLOBE NEWSWIRE) -- NANOX IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, announced today the appointment of Moshe Shtengel as Chief Business Officer, effective May 2, 2021. Mr. Shtengel joins Nanox from Tuttnauer, a global manufacturer of sterilizers and infection control systems for medical institutions, where he served as Vice President of Global Sales, Marketing and Products. "Moshe is an extremely seasoned sales and business development executive with a proven track record of success and leadership in the medical field," stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox. "As we

      5/3/21 8:00:00 AM ET
      $NNOX
      Medical Electronics
      Health Care

    $NNOX
    SEC Filings

    See more

    $NNOX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SEC Form 6-K filed by NANO-X IMAGING LTD

      6-K - Nano-X Imaging Ltd. (0001795251) (Filer)

      4/17/25 8:40:02 AM ET
      $NNOX
      Medical Electronics
      Health Care
    • SEC Form 20-F filed by NANO-X IMAGING LTD

      20-F - Nano-X Imaging Ltd. (0001795251) (Filer)

      4/9/25 4:29:36 PM ET
      $NNOX
      Medical Electronics
      Health Care
    • SEC Form 6-K filed by NANO-X IMAGING LTD

      6-K - Nano-X Imaging Ltd. (0001795251) (Filer)

      3/31/25 8:37:25 AM ET
      $NNOX
      Medical Electronics
      Health Care
    • D. Boral Capital initiated coverage on Nano-X Imaging with a new price target

      D. Boral Capital initiated coverage of Nano-X Imaging with a rating of Buy and set a new price target of $23.00

      1/6/25 9:02:00 AM ET
      $NNOX
      Medical Electronics
      Health Care
    • Alliance Global Partners initiated coverage on Nano-X Imaging with a new price target

      Alliance Global Partners initiated coverage of Nano-X Imaging with a rating of Buy and set a new price target of $14.50

      9/8/23 9:14:06 AM ET
      $NNOX
      Medical Electronics
      Health Care
    • Cantor Fitzgerald initiated coverage on Nano-X Imaging with a new price target

      Cantor Fitzgerald initiated coverage of Nano-X Imaging with a rating of Overweight and set a new price target of $21.00

      1/5/23 7:46:34 AM ET
      $NNOX
      Medical Electronics
      Health Care

    $NNOX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by NANO-X IMAGING LTD (Amendment)

      SC 13G/A - Nano-X Imaging Ltd. (0001795251) (Subject)

      3/7/24 12:29:51 PM ET
      $NNOX
      Medical Electronics
      Health Care
    • SEC Form SC 13G filed by NANO-X IMAGING LTD

      SC 13G - Nano-X Imaging Ltd. (0001795251) (Subject)

      2/6/24 9:36:34 AM ET
      $NNOX
      Medical Electronics
      Health Care
    • SEC Form SC 13G/A filed by NANO-X IMAGING LTD (Amendment)

      SC 13G/A - Nano-X Imaging Ltd. (0001795251) (Subject)

      2/14/23 4:15:16 PM ET
      $NNOX
      Medical Electronics
      Health Care